Mechanisms of Resistance in Nontyphoidal Salmonella enterica Strains Exhibiting a Nonclassical Quinolone Resistance Phenotype

被引:53
作者
Gunell, Marianne [1 ,2 ]
Webber, Mark A. [3 ]
Kotilainen, Pirkko [1 ,2 ,4 ,5 ]
Lilly, Andrew J. [3 ]
Caddick, Jonathan M. [3 ]
Jalava, Jari [1 ,2 ]
Huovinen, Pentti [1 ,2 ]
Siitonen, Anja [6 ,7 ]
Hakanen, Antti J. [1 ,2 ,4 ,5 ]
Piddock, Laura J. V. [3 ]
机构
[1] Natl Inst Hlth & Welf, Antimicrobial Resistance Unit, Turku, Finland
[2] Natl Inst Hlth & Welf, Antimicrobial Resistance Unit, Helsinki, Finland
[3] Univ Birmingham, Sch Immun & Infect, Antimicrobial Agents Res Grp, Birmingham B15 2TT, W Midlands, England
[4] Turku Univ Hosp, Dept Med, FIN-20520 Turku, Finland
[5] Univ Turku, Turku, Finland
[6] Natl Inst Hlth & Welf THL, Gastrointestinal Infect Unit, Turku, Finland
[7] Natl Inst Hlth & Welf THL, Gastrointestinal Infect Unit, Helsinki, Finland
基金
英国生物技术与生命科学研究理事会;
关键词
REDUCED FLUOROQUINOLONE SUSCEPTIBILITY; SPECTRUM BETA-LACTAMASE; ESCHERICHIA-COLI; UNITED-STATES; ANTIBIOTIC-RESISTANCE; KLEBSIELLA-PNEUMONIAE; MODIFYING ENZYME; QNR PREVALENCE; PLASMID; TRAVELERS;
D O I
10.1128/AAC.00121-09
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Nontyphoidal Salmonella enterica strains with a nonclassical quinolone resistance phenotype were isolated from patients returning from Thailand or Malaysia to Finland. A total of 10 isolates of seven serovars were studied in detail, all of which had reduced susceptibility (MIC >= 0.125 mu g/ml) to ciprofloxacin but were either susceptible or showed only low-level resistance (MIC <= 32 mu g/ml) to nalidixic acid. Phenotypic characterization included susceptibility testing by the agar dilution method and investigation of efflux activity. Genotypic characterization included the screening of mutations in the quinolone resistance-determining regions (QRDR) of gyrA, gyrB, parC, and parE by PCR and denaturing high-pressure liquid chromatography and the amplification of plasmid-mediated quinolone resistance (PMQR) genes qnrA, qnrB, qnrS, qnrD, aac(6')-Ib-cr, and qepA by PCR. PMQR was confirmed by plasmid analysis, Southern hybridization, and plasmid transfer. No mutations in the QRDRs of gyrA, gyrB, parC, or parE were detected with the exception of a Thr57-Ser substitution within ParC seen in all but the S. enterica serovar Typhimurium strains. The qnrA and qnrS genes were the only PMQR determinants detected. Plasmids carrying qnr alleles were transferable in vitro, and the resistance phenotype was reproducible in Escherichia coli DH5 alpha transformants. These data demonstrate the emergence of a highly mobile qnr genotype that, in the absence of mutation within topoisomerase genes, confers the nontypical quinolone resistance phenotype in S. enterica isolates. The qnr resistance mechanism enables bacteria to survive elevated quinolone concentrations, and therefore, strains carrying qnr alleles may be able to expand during fluoroquinolone treatment. This is of concern since nonclassical quinolone resistance is plasmid mediated and therefore mobilizable.
引用
收藏
页码:3832 / 3836
页数:5
相关论文
共 35 条
[1]   Is it time to change fluoroquinolone breakpoints for Salmonella spp.? [J].
Aarestrup, FM ;
Wiuff, C ;
Molbak, K ;
Threlfall, EJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) :827-829
[2]   Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates [J].
Cattoir, Vincent ;
Poirel, Laurent ;
Rotimi, Vincent ;
Soussy, Claude-James ;
Nordmann, Patrice .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (02) :394-397
[3]   qnrD, a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human Origin [J].
Cavaco, L. M. ;
Hasman, H. ;
Xia, S. ;
Aarestrup, F. M. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) :603-608
[4]   Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes [J].
Cesaro, Annabelle ;
Bettoni, Romain Roth Dit ;
Lascols, Christine ;
Merens, Audrey ;
Soussy, Claude James ;
Cambau, Emmanuelle .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (05) :1007-1015
[5]  
Clinical and Laboratory Standards Institute, 2006, M07A7 CLSI
[6]  
Clinical and Laboratory Standards Institute (CLSI), 2007, M100S17 CLSI
[7]   Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica [J].
Eaves, DJ ;
Randall, L ;
Gray, DT ;
Buckley, A ;
Woodward, MJ ;
White, AP ;
Piddock, LJV .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) :4012-4015
[8]   Detection of gyrA mutations in quinolone-resistant Salmonella enterica by denaturing high-performance liquid chromatography [J].
Eaves, DJ ;
Liebana, E ;
Woodward, MJ ;
Piddock, LJV .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (11) :4121-4125
[9]   Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from southeast Asia [J].
Hakanen, A ;
Kotilainen, P ;
Huovinen, P ;
Helenius, H ;
Siitonen, A .
EMERGING INFECTIOUS DISEASES, 2001, 7 (06) :996-1003
[10]   Detection of decreased fluoroquinolone susceptibility in salmonellas and validation of nalidixic acid screening test [J].
Hakanen, A ;
Kotilainen, P ;
Jalava, J ;
Siitonen, A ;
Huovinen, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (11) :3572-3577